Profile
Tuomas Pertti Knowles is the founder of Fluidic Analytics Ltd., founded in 2013, holding the title of Director & Chief Scientific Officer since 2015.
Dr. Knowles is the founder of Wavebreak Therapeutics Ltd., founded in 2016.
Dr. Knowles is the founder of Xampla Ltd., founded in 2018.
Dr. Knowles is also the founder of Transition Bio, Inc...
Dr. Knowles holds a doctorate from the University of Cambridge.
Tuomas Knowles active positions
| Companies | Position | Start |
|---|---|---|
Fluidic Analytics Ltd.
Fluidic Analytics Ltd. BiotechnologyHealth Technology Develops proprietary technology to characterize proteins | Founder | 17/10/2013 |
Transition Bio, Inc.
Transition Bio, Inc. BiotechnologyHealth Technology Provides condensate technology for drug discovery and diagnostics | Founder | - |
Former positions of Tuomas Knowles
| Companies | Position | End |
|---|---|---|
Xampla Ltd.
Xampla Ltd. Pharmaceuticals: OtherHealth Technology Research and develops plant protein material | Founder | - |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Founder | - |
Training of Tuomas Knowles
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fluidic Analytics Ltd.
Fluidic Analytics Ltd. BiotechnologyHealth Technology Develops proprietary technology to characterize proteins | Health Technology |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics for multiple protein misfolding diseases | Health Technology |
Xampla Ltd.
Xampla Ltd. Pharmaceuticals: OtherHealth Technology Research and develops plant protein material | Health Technology |
Transition Bio, Inc.
Transition Bio, Inc. BiotechnologyHealth Technology Provides condensate technology for drug discovery and diagnostics | Health Technology |
- Stock Market
- Insiders
- Tuomas Knowles
















